Clinical trials
Withdrawn Alcoholism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 9 |
| Yale University | 4 |
| Brigham and Women's Hospital | 2 |
| National Center for Complementary and Integrative Health (NCCIH) | 2 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2 |
| Stanford University | 2 |
| University of California, Los Angeles | 2 |
| Central Institute of Mental Health, Mannheim | 1 |
| Centre Hospitalier Arras | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcoholism | 56 |
| Substance-Related Disorders | 12 |
| Alcohol-Related Disorders | 5 |
| Stress Disorders, Post-Traumatic | 4 |
| Tobacco Use Disorder | 4 |
| Marijuana Abuse | 2 |
| Mental Disorders | 2 |
| Alcoholic Intoxication | 1 |
| Arthritis, Juvenile | 1 |
| Binge Drinking | 1 |
Trials
Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.